We are live on
!
Find out more
ACP
Acuta Capital Partners Portfolio holdings
AUM
$141M
1-Year Est. Return
783.79%
This Fund
S&P 500
This Quarter
Est. Return
+42.28%
1 Year Est. Return
+783.79%
3 Year Est. Return
+7,472.18%
5 Year Est. Return
+13,792.16%
10 Year Est. Return
+1,629,663.73%
AUM
$141M
AUM Growth
-$6.69M
(-4.5%)
Cap. Flow
-$27M
Cap. Flow
% of AUM
-19.21%
Top 10 Holdings %
Top 10 Hldgs %
78%
Holding
35
New
5
Increased
6
Reduced
13
Closed
9
Top Buys
| 1 |
Erasca
ERAS
|
+$4.19M |
| 2 |
Sutro Biopharma
STRO
|
+$3.65M |
| 3 |
DRUG
Bright Minds Biosciences
DRUG
|
+$2.22M |
| 4 |
Tango Therapeutics
TNGX
|
+$2.21M |
| 5 |
MoonLake Immunotherapeutics
MLTX
|
+$2.19M |
Top Sells
| 1 |
CDTX
Cidara Therapeutics
CDTX
|
+$19.7M |
| 2 |
TERN
Terns Pharmaceuticals
TERN
|
+$5.8M |
| 3 |
Jazz Pharmaceuticals
JAZZ
|
+$4.93M |
| 4 |
Insmed
INSM
|
+$4.5M |
| 5 |
Ocular Therapeutix
OCUL
|
+$4.39M |
Sector Composition
| 1 | Healthcare | 98.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CDTX
26
DELISTED
Cidara Therapeutics
CDTX
| – | – |
-89,145
| Closed | -$19.7M |
|
27
Dianthus Therapeutics
DNTH
$5.54B
| – | – |
-16,708
| Closed | -$689K |
|
28
Inhibrx
INBX
$1.37B
| – | – |
-16,377
| Closed | -$1.29M |
|
|
29
Insmed
INSM
$23.9B
| – | – |
-25,878
| Closed | -$4.5M |
|
|
30
Jazz Pharmaceuticals
JAZZ
$15B
| – | – |
-29,008
| Closed | -$4.93M |
|
31
Pasithea Therapeutics
KTTA
$16.1M
| – | – |
-450,000
| Closed | -$581K |
|
|
NUVB.WS
32
DELISTED
Nuvation Bio Inc Warrants
NUVB.WS
| – | – |
-90,832
| Closed | -$30K |
|
33
Verastem
VSTM
$489M
| – | – |
-143,446
| Closed | -$1.11M |
|
34
Zymeworks
ZYME
$1.81B
| – | – |
-80,143
| Closed | -$2.11M |
|
Similar funds
MQWP
OWM
VT
API
APW
SM
VEM
MWM